Dentsply Sirona Appoints New CEO, Reaffirms 2025 Outlook Amid Preliminary Q2 Results

Dentsply Sirona Inc appointed Daniel Scavilla as its new President and CEO, effective August 1, 2025. The company also provided preliminary Q2 2025 financial results, expecting net sales of $935 million and adjusted EPS between $0.50 and $0.52. Dentsply Sirona reaffirmed its 2025 outlook, with final results to be reported on August 7, 2025. The appointment of Scavilla and reaffirmation of the 2025 outlook are positive signals for the company's growth and innovation, but the leadership transition may bring short-term uncertainties.

Charlotte, N.C. — Dentsply Sirona Inc. (Nasdaq: XRAY) has appointed Daniel Scavilla as its new President and Chief Executive Officer, effective August 1, 2025. Scavilla succeeds Simon Campion, who is stepping down on July 31, 2025. Scavilla brings over three decades of experience in the medical technology and pharmaceutical sectors, most recently serving as President and CEO of Globus Medical, where he led the acquisition of NuVasive and oversaw the integration of the two organizations to create the world's second largest spine technology company.

The appointment of Scavilla underscores the company's commitment to delivering enhanced value to shareholders and positioning itself for future success. Scavilla was appointed to the Dentsply Sirona Board in February 2025 and will continue to serve as a director, though he will no longer serve on the Board’s Audit and Finance Committee.

In conjunction with the leadership transition, Dentsply Sirona also announced select preliminary financial results for the second quarter of 2025. The company expects to report net sales of approximately $935 million and adjusted earnings per share (EPS) between $0.50 and $0.52. The company reaffirmed its 2025 outlook, with final results to be reported on August 7, 2025.

Scavilla expressed his commitment to improving Dentsply Sirona’s performance and capitalizing on untapped opportunities in the dental market. "The Board and I are aligned in our belief that, while our ongoing transformation is yielding results, there is more we can do to drive improved commercial, operational, and financial performance across the organization," Scavilla said.

The appointment of Scavilla and the reaffirmation of the 2025 outlook are positive signals for the company's growth and innovation. However, the leadership transition may bring short-term uncertainties. Investors will be closely watching Scavilla's strategic moves and the company's progress towards its 2025 targets.

References:
[1] https://investor.dentsplysirona.com/news-releases/news-release-details/dentsply-sirona-appoints-daniel-scavilla-chief-executive-officer
[2] https://www.quiverquant.com/news/Dentsply+Sirona+Appoints+Daniel+Scavilla+as+President+and+CEO%2C+Effective+August+1%2C+2025